NEW YORK, Oct 16 - DoubleTwist, next in the bioinformatics IPO queue, is seeking to raise at least $65 million through an offer of 5 million shares in a proposed price range of $13 to $15 a share, according to an S-1 amendment the company filed Friday.

The company, which originally announced its plan to go public on Sept. 1, has applied to be listed on the Nasdaq under the symbol DBLT. A DoubleTwist spokeswoman said that the date the company's stock would begin trading has not yet been determined.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.